Avail 30% Discount Now: Premium Insights at Discounted Price (Discount will be Applied at Checkout)

Global Tnf Alpha Inhibitors Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drug;

Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol) and Simponi (golimumab.

Segmented by Route of Administration;

Oral, Subcutaneous, Intravenous and Others.

Segmented by Disease Type;

Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn962772903 Published Date: October, 2022 Updated Date: November, 2022

Introduction

Global Tnf Alpha Inhibitors Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 70.5
2019 72.7
2020 79.0
2021 86.5
2022 101.5
2023 114.3
2024 129.9
2025 139.7
2026 164.8
2027 170.0
2028 171.5

In the year 2021, the Global Tnf Alpha Inhibitors Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Disease Type
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Tnf Alpha Inhibitors Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Tnf Alpha Inhibitors Market, By Drug, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Remicade (infliximab)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Enbrel (etanercept)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Humira (adalimumab)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Cimzia (certolizumab pegol)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Simponi (golimumab
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Tnf Alpha Inhibitors Market, By Route of Administration, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Subcutaneous
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Intravenous
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Tnf Alpha Inhibitors Market, By Disease Type, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Inflammatory Bowel Disease
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Psoriatic Arthritis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Ulcerative Colitis (UC)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Rheumatoid Arthritis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Ankylosing Spondylitis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    4. Global Tnf Alpha Inhibitors Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AbbVie Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Amgen Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Johnson & Johnson Services, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. UCB S.A
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Novartis International AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices Tnf Inhibitors
Global Tnf Inhibitors Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Tnf Inhibitors Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Healthcare IT Top 10 Bioprocess Technology
Global Top 10 Bioprocess Technology Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Top 10 Bioprocess Technology Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Healthcare IT Top 10 Cellular Analysis
Global Top 10 Cellular Analysis Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Top 10 Cellular Analysis Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Topical Analgesic
Global Topical Analgesic Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Topical Analgesic Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...